Re: ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma (92:31-39) by Lassus et al.
Marzano
Raffaella
R
Orlandi
Giulia
G
Corrado
Giacomo
G
D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D018284:Cystadenocarcinoma, Serous / Q000235:genetics* / Q000378:metabolism; D005260:Female; D005784:Gene Amplification; D018734:Genes, erbB-2 / Q000235:genetics; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis / Q000235:genetics*
D018719:Erb-b2 Receptor Tyrosine Kinases